GLGuey-Jen Lee-Chen

Guey-Jen Lee-Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guey-Jen Lee-Chen has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Chiung-Mei Chen

    Department of Neurology, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taipei 105, Taiwan

    2 shared publications
  • Der-Yan Tai

    Department of Internal Medicine, Wei Gong Memorial Hospital, Tou Fen, Miaoli 351, Taiwan, ROC

    2 shared publications
  • Ju-Pin Pan

    Department of Medicine, Division of Cardiology, Veterans General Hospital-Taipei, National Yang-Ming University, School of Medicine, Taipei 112, Taiwan, ROC

    2 shared publications
  • Sp Lin

    The first two authors contributed equally to this work

    2 shared publications
  • Yih-Ru Wu

    Department of Neurology, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taipei 105, Taiwan

    2 shared publications
  • Bing-Wen Soong

    Neurological Institute, Taipei Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei 112, Taiwan

    1 shared publication

Latest Publications

  • Expanded trinucleotide repeats in the TBP/SCA17 gene mapped to chromosome 6q27 are associated with schizophrenia

    by Chiung-Mei Chen, Hsien-Yuan Lane, Yih-Ru Wu, Long-Sun Ro, Fen-Lin Chen, Wei-Ling Hung, Yi-Ting Hou, Cheng-Yueh Lin, Shu-Yi Huang, I-Cheng Chen, et al.


  • Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II)

    by Jui-Hung Chang, Shuan-Pei Lin, Shu-Chuan Lin, Kai-Li Tseng, Chia-Ling Li, Chih-Kuang Chuang, Guey-Jen Lee-Chen

    Nearly 300 different mutations underlying mucopolysaccharidosis type II (MPS II) have been identified worldwide. To investigate the molecular lesions underlying Taiwanese MPS II, probands and families were identified and screened for iduronate-2-sulfatase (IDS) mutation by single-strand conformation polymorphism and DNA sequencing. Five novel and five previously reported mutations were found. Together with those previously reported, a total of 17 identified missense, small deletion, and nonsense mutations were further characterized by transient expression studies. Transfection of COS-7 cells by the mutated cDNA did not yield active enzyme, demonstrating the deleterious nature of the mutations. A 57% decrease in IDS mRNA level was seen with the 231del6 mutation. Among the 11 missense mutations examined, K347E substitution showed apparent normal maturation and targeting on immunoblot and confocal fluorescence microscopy examination. The other 10 missense mutations showed apparent normal precursor with little or reduced mature forms, indicating normal maturation but incorrect targeting of the mutant enzymes. Among the six deletion and nonsense mutations examined, 1055del12 and E521X showed abnormal maturation. The staining pattern of the truncated W267X and 1184delG proteins suggested retention within early vacuolar compartments. The mutated 231del6 and 1421delAG proteins were unstable and largely degraded. Molecular analysis of the IDS gene will clearly identify the cause of the disease within patients and allow antenatal and family studies. The further characterization of gene mutations may delineate their functional consequences on IDS activity and processing and may enable future studies of genotype–phenotype correlation to estimate a prognosis and to lead to possible therapeutic interventions.


  • Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux

    by Kuo-Pao Liu, Ching-Yuang Lin, Han-Jou Chen, Chou-Fu Wei, Guey-Jen Lee-Chen

    We studied the angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms for association with susceptibility to primary vesicoureteral reflux (VUR) and disease progression in 74 Taiwanese children, including 16 with end-stage renal disease (ESRD), and 117 normal controls. Polymerase chain reaction-amplified products containing the ACE gene T-5491C, A-5466C, T-3892C, A-3692C, A-240T, Alu I/D, the AGT gene C-532T, G-217A, G-152A, A-20C, A-6G, T174M, T235M, and the AT1R gene A-1138T, T-810A, T-713G, C-521T, AG-214CC, A-153G, A1166C polymorphisms were analyzed by restriction enzyme digestion, gel electrophoresis, or single-strand conformation polymorphism analysis. All the polymorphisms examined were in Hardy-Weinberg equilibrium. The strong non-random association within the ACE, AGT, and AT1R genes suggests low levels of intragenic recombination. None of these polymorphisms showed association with VUR susceptibility. However, the allele frequency distribution of the six ACE polymorphisms among primary VUR patients with or without ESRD was statistically different. The linked ACE T-A-T-A-A-I allele was observed significantly more frequently in VUR children with ESRD (P AGT A-6G genotype frequencies were significantly different when the analysis was stratified by genotype of the ACE polymorphisms. The data showed that ACE gene polymorphisms were associated with progressive renal deterioration in Taiwanese children with VUR and might act synergistically with the −6 G allele of the AGT gene.


  • Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson?s disease

    by Chiung-Mei Chen, Yuying Hsu, Sih-Jing Lin, Kuo-Hsuan Chang, Guey-Jen Lee-Chen, Cheng-Kuang Wang, Yi-Ying Lin, Yih-Ru Wu, Hon-Chung Fung

    Parkinson’s disease (PD) involves several genetic and environmental components. Heat-shock protein 70, a chaperone that is up-regulated in stress responses and that refolds protein, may be involved in the pathogenesis of PD. We have investigated the association of polymorphisms −110 A/C, +190 G/C, +1267 A/G, +2074 G/C, and +2437 G/C in the 5’ and coding regions of the HSP70-1, HSP70-2, and HSP70-hom genes with the risk of PD by screening DNA samples from 274 PD patients and 183 controls in assays based on the polymerase chain reaction. There was no statistically significant difference in genotype distribution between patients and controls for the three coding-region polymorphisms in HSP70-2 and HSP70-hom. However, for HSP70-1, the overall genotype distribution was significantly different at the −110 site (P=0.004) and tended to be different at the +190 site (P=0.012) between patients and controls. The frequencies of the −110 CC and +190 CC genotypes were significantly higher in PD patients than in controls (P=0.001 and 0.006, respectively). Both −110 CC (odds ratio: 2.91; 95% CI: 1.51–5.96; P=0.002) and +190 CC (odds ratio: 3.59; 95% CI: 1.53–9.88; P=0.006) genotypes were significantly associated with PD. Reporter constructs containing the −110 A allele cloned into a luciferase reporter plasmid drove marginally higher transcriptional activity of HSP70-1 compared with the −110 C allele in both control and heat-shocked IMR32 and 293 cells. Therefore, −110 A/C may be a functional polymorphism in the 5’ promoter region of HSP70-1 and may affect susceptibility to PD.


  • Identification and characterization of mutations underlying Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA)

    by Gj Lee‐Chen, Sp Lin, Mh Ko, Ck Chuang, Cp Chen, Hh Lee, Sc Cheng, Ch Shen, Kl Tseng, Cl Li

    Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA; MPS IIIA) is caused by a deficiency of the lysosomal enzyme haparan N‐sulphatase (NS). The genomic DNA segments of the NS gene from two Chinese patients with MPS IIIA were amplified by polymerase chain reaction, followed by DNA sequencing to study the molecular lesions. Four mutations (i.e. N42K, D235N, P293S and R377C) and five polymorphisms (i.e. IVS2‐72A → G, IVS2‐26T → C, IVS5+17C → T, IVS5‐37GC → CTGT and R456H) were identified. Transfection of COS‐7 cells with cDNA mutagenized to the corresponding mutations did not yield active enzyme, demonstrating the deleterious nature of the mutations. Western blot analysis revealed a 62‐kDa precursor and 56‐kDa mature forms for cells transfected with wild‐type and polymorphic R456H enzymes. For cells transfected with mutant enzymes, the reduction in precursor and mature forms suggests an increased degradation of the mutant enzymes. The polymorphic DNA haplotype of the NS gene was analysed in 52 unrelated subjects. All five polymorphisms were in Hardy–Weinberg equilibrium. The strong non‐random association among the five polymorphisms suggests little or no recombination in the NS gene.


  • Mucopolysaccharidosis type I: Characterization of novel mutations affecting α‐ l‐iduronidase activity

    by Gj Lee‐Chen, Sp Lin, Yf Tang, Yw Chin

    α‐ l‐Iduronidase (IDUA) deficiency (mucopolysaccharidosis type I, MPS I) involves a broad spectrum of clinical severity ranging from a severe Hurler syndrome through an intermediate Hurler–Scheie syndrome to a mild Scheie syndrome. To date, a number of mutations of the IDUA gene are known in Hurler syndrome, but only a few in Hurler–Scheie or Scheie syndrome. The characterization of novel mutations in two patients with the Hurler–Scheie syndrome is reported on. The novel R619G mutation (C–G transversion in codon 619) was apparently homozygous. In transfected COS‐7 cells, R619G caused significant reduction in enzyme activity (1.5% of normal activity), although it did not cause significant reduction in IDUA mRNA or protein level. Conversely, the previously described homozygous T364M mutation (C–T transition in codon 364) caused a decrease in the level of IDUA mRNA. Studies inhibiting RNA synthesis with actinomycin d or inhibiting protein synthesis with cycloheximide demonstrate that the decrease in the latter mutation is attributable to an increased rate of mRNA decay. By examining the stability of IDUA mRNA and protein, studies provide better insight into the effect of mutation on IDUA activity.


  • Open Access

    Identification and haplotype analysis of apolipoprotein B-100 Arg3500→Trp mutation in hyperlipidemic Chinese

    by Der-Yan Tai, Ju-Pin Pan, Guey-Jen Lee-Chen

    DNA screening for apolipoprotein (apo) B-100 mutations was performed in hyperlipidemic Chinese. The apo B-100 gene segment surrounding previously identified familial defective apo B-100 (FDB) mutations was amplified by PCR and subjected to single-strand conformation polymorphism (SSCP) analysis. One subject’s aberrant SSCP band was cloned and sequenced to study the molecular lesions. A recurrent ArgCGG-to-TrpTGG mutation (R3500W) in the codon 3500 of the apo B-100 gene was identified. The C-to-T transition creates a NlaIII site and permits rapid restriction analysis of the mutation. A total of 373 hyperlipidemic patients and 309 controls were screened for R3500W. Nine unrelated subjects were shown to be heterozygous for the mutation, and no R3500W carriers were found in the control group (P = 0.004). Six polymorphic markers, including five restriction fragment length polymorphisms and one hypervariable repeat region, were used for haplotype analysis on the mutant allele. In two families, the R3500W mutation could be unambiguously assigned to a unique haplotype XbaI−/MaeI+/MspI+/EcoRI+/Eco57I+/34 3′HVR repeats; in the other seven unrelated heterozygotes, this finding was consistent when an unequivocal haplotype was deduced. The results suggest that all R3500W alleles are identical by descent in our population. The fact that the same mutant allele was identified in other Asians with FDB indicates a common Asian origin for the R3500W mutations.